Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText.
Kick-your-searchterm to multiple Engines kick-your-query now !>
A dictionary by aggregated review articles of nephrology, medicine and the life sciences
Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

suck abstract from ncbi


10.1021/acs.jproteome.0c00637

http://scihub22266oqcxt.onion/10.1021/acs.jproteome.0c00637
suck pdf from google scholar
33301685!ä!33301685

suck abstract from ncbi


Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534

Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
pmid33301685      J+Proteome+Res 2021 ; 20 (1): 139-153
Nephropedia Template TP

gab.com Text

Twit Text FOAVip

Twit Text #

English Wikipedia


  • COVID-19: The Effect of Host Genetic Variations on Host-Virus Interactions #MMPMID33301685
  • Chakravarty S
  • J Proteome Res 2021[Jan]; 20 (1): 139-153 PMID33301685show ga
  • Spurred into action by the COVID-19 pandemic, the global scientific community has, in a short of period of time, made astonishing progress in understanding and combating COVID-19. Given the known human protein machinery for (a) SARS-CoV-2 entry, (b) the host innate immune response, and (c) virus-host interactions (protein-protein and RNA-protein), the potential effects of human genetic variation in this machinery, which may contribute to clinical differences in SARS-CoV-2 pathogenesis and help determine individual risk for COVID-19 infection, are explored. The Genome Aggregation Database (gnomAD) was used to show that several rare germline exome variants of proteins in these pathways occur in the human population, suggesting that carriers of these rare variants (especially for proteins of innate immunity pathways) are at risk for severe symptoms (like the severe symptoms in patients who are known to be rare variant carriers), whereas carriers of other variants could have a protective advantage against infection. The occurrence of genetic variation is thus expected to motivate the experimental probing of natural variants to understand the mechanistic differences in SARS-CoV-2 pathogenesis from one individual to another.
  • |*Genetic Variation[MESH]
  • |Angiotensin-Converting Enzyme 2/chemistry/genetics/metabolism[MESH]
  • |COVID-19/*genetics/immunology[MESH]
  • |Host-Pathogen Interactions/*genetics[MESH]
  • |Humans[MESH]
  • |Immunity, Innate/genetics[MESH]
  • |Quantitative Trait Loci[MESH]
  • |RNA, Viral/metabolism[MESH]
  • |SARS-CoV-2/*pathogenicity[MESH]
  • |Toll-Like Receptor 3/genetics[MESH]
  • |Toll-Like Receptor 7/genetics[MESH]


  • DeepDyve
  • Pubget Overpricing
  • suck abstract from ncbi

    Linkout box